Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study

Sue Ann Costa Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, Hui-Ling Chen, Igor Smolenov, Andrew Pollard, Ralf Clemens
doi: https://doi.org/10.1101/2022.05.31.22275010

Article usage

Article usage: June 2022 to December 2024

AbstractFullPdf
Jun 2022168134246
Jul 2022652336
Aug 2022579728
Sep 202279015
Oct 202273024
Nov 202262116
Dec 202258218
Jan 202326511
Feb 20233258
Mar 20233535
Apr 20232915
May 202321212
Jun 20231252
Jul 2023527
Aug 202322109
Sep 20231743
Oct 20231546
Nov 202325135
Dec 20231455
Jan 2024742
Feb 20241569
Mar 202419314
Apr 20241539
May 2024644
Jun 20241866
Jul 202413313
Aug 20241133
Sep 20242246
Oct 20241178
Nov 2024708
Dec 2024001
Back to top
Posted June 02, 2022.
Download PDF
Data/Code
Email
Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study
Sue Ann Costa Clemens, Eveline Pipolo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, Hui-Ling Chen, Igor Smolenov, Andrew Pollard, Ralf Clemens
medRxiv 2022.05.31.22275010; doi: https://doi.org/10.1101/2022.05.31.22275010
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area